Unpacking the 2024 Election in Preparation for 2025

WATCH NOW
Session Highlights:

In this complimentary webinar, FDA giants Kurt Karst and Maarika Kimbrell will explore how the election outcomes reshape health care policy in Congress and pivotal agencies such as Food and Drug Administration.

Topics of discussion will include:

  • Evaluating what the political appointments to the FDA and CMS suggest for the future of regulatory policy
  • Scrutinizing the proposed policy reforms and healthcare agenda of the new administration and Congress
  • Exploring the impact that the legislative and regulatory changes will have on regulatory strategy

Reproducing the session either audio or video is not permitted without prior express written consent of The Canadian Institute. Speaker permission must be obtained for use of presentation content in news coverage/articles.

Speaker

Kurt R. Karst

Director
Hyman, Phelps & McNamara, P.C.

Speaker

Maarika L. Kimbrell

Partner
Morgan, Lewis & Bockius LLP
Former FDA Director, OND and CDER